25
Participants
Start Date
December 8, 2021
Primary Completion Date
December 30, 2023
Study Completion Date
December 30, 2023
Cosibelimab
IV infusion
Cisplatin
IV infusion
Carboplatin
IV infusion
Pemetrexed
IV infusion
Folic acid 350-1000 μg
Orally; at least 5 doses of folic acid must be taken during the 7 days preceding the first dose of pemetrexed, and folic acid dosing must continue during the full course of therapy and for 21 days after the last dose of pemetrexed.
Vitamin B12 1000 μg
Intramuscular injection in the week preceding the first dose of pemetrexed and once every 3 cycles thereafter. Subsequent vitamin B12 injections may be given the same day as pemetrexed administration.
Dexamethasone 4mg
For prophylaxis; orally twice per day (or equivalent). Taken the day before, day of, and day after pemetrexed administration.
Research Site, Vitória
Research Site, Tbilisi
Research Site, Kota Bharu
Research Site, Wellington
Research Site, Lima
Research Site, Arkhangelsk
Research Site, Chelyabinsk
Research Site, Kaliningrad
Research Site, Kazan'
Research Site, Kursk
Research Site, Kuzmolovskiy
Research Site, Moscow
Research Site, Nizhny Novgorod
Research Site, Novosibirsk
Research Site, Omsk
Research Site, Saint Petersburg
Research Site, Samara
Research Site, Sochi
Research Site, Tomsk
Research Site, Volgograd
Research Site, Pretoria
Research Site, Chiang Mai
Lead Sponsor
Checkpoint Therapeutics, Inc.
INDUSTRY